Protection against fatalPseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides

[1]  Irmgard Habs.  Untersuchungen über die O-Antigene von Pseudomonas aeruginosa , 1957, Zeitschrift für Hygiene und Infektionskrankheiten.

[2]  R. Hancock,et al.  Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species , 1984, Infection and immunity.

[3]  T. Pitt,et al.  Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa , 1984, Infection and immunity.

[4]  S. Cryz,et al.  Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide , 1984, Infection and immunity.

[5]  S. Cryz.  11 – Pseudomonas aeruginosa Infections , 1984 .

[6]  C S Bryan,et al.  Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. , 1983, Reviews of infectious diseases.

[7]  P. Rowe,et al.  Structure of the Core oligosaccharide from the lipopolysaccharide of Pseudomonas aeruginosa PAC1R and its defective mutants. , 1983, European journal of biochemistry.

[8]  S. Cryz,et al.  Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide , 1983, Infection and immunity.

[9]  G. Bodey,et al.  Infections caused by Pseudomonas aeruginosa. , 1983, Reviews of infectious diseases.

[10]  G. Pier,et al.  Lipopolysaccharide and high-molecular-weight polysaccharide serotypes of Pseudomonas aeruginosa. , 1982, The Journal of infectious diseases.

[11]  W. Hickey,et al.  Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs. , 1981, The Journal of clinical investigation.

[12]  U. Ullmann,et al.  Distribution of Pseudomonas aeruginosa serotypes in bacteriologic specimens and their aminoglycoside resistance. , 1980, Zentralblatt fur Bakteriologie. 1. Abt. Originale. A: Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie.

[13]  W. R. Mccabe,et al.  Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. , 1980, The American journal of medicine.

[14]  P. Meadow,et al.  Receptor Sites for R-type Pyocins and Bacteriophage E79 in the Core Part of the Lipopolysaccharide of Pseudomonas aeruginosaPAC1 , 1978 .

[15]  M. Vasil,et al.  Effect of iron on yields of exotoxin A in cultures of Pseudomonas aeruginosa PA-103 , 1978, Infection and immunity.

[16]  M. Fisher.  A polyvalent human gamma-globulin immune to Pseudomonas aeruginosa: passive protection of mice against lethal infection. , 1977, The Journal of infectious diseases.

[17]  H. Reynolds,et al.  Experimental pneumonia due to Pseudomonas aeruginosa in leukopenic dogs: prolongation of survival by combined treatment with passive antibody to Pseudomonas and granulocyte transfusions. , 1977, The Journal of infectious diseases.

[18]  S. Koval,et al.  The isolation and characterization of lipopolysaccharide-defective mutants of Pseudomonas aeruginosa PAC1. , 1977, Journal of general microbiology.

[19]  L. Cluff,et al.  Pseudomonas bacteremia. Review of 108 cases. , 1976, The American journal of medicine.

[20]  Shriniwas.  Nosocomial infections due to Pseudomonas aeruginosa. , 1975, Indian pediatrics.

[21]  M. Finland,et al.  Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases. , 1975, The Journal of infectious diseases.

[22]  I. A. Holder,et al.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. , 1975, The Journal of infectious diseases.

[23]  R. Germanier,et al.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. , 1975, The Journal of infectious diseases.

[24]  J. McCutchan,et al.  Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum. , 1975, Transactions of the Association of American Physicians.

[25]  T. Pitt,et al.  The relationship between the O-antigenic lipopolysaccharides and serological specificity in strains of Pseudomonas aeruginosa of different O-serotypes. , 1973, Journal of general microbiology.

[26]  J. G. Crowder,et al.  Type-specific immunity in pseudomonas diseases. , 1972, The Journal of laboratory and clinical medicine.

[27]  O. S. Mikkelsen.  Serotyping of Pseudomonas aeruginosa. 2. Results of an O group classification. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[28]  A. Elbein,et al.  THE BIOSYNTHESIS OF CELL WALL LIPOPOLYSACCHARIDE IN ESCHERICHIA COLI. I. THE BIOCHEMICAL PROPERTIES OF A URIDINE DIPHOSPHATE GALACTOSE 4-EPIMERASELESS MUTANT. , 1965, The Journal of biological chemistry.